KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Change in Taxes (2016 - 2026)

Bristol Myers Squibb has reported Change in Taxes over the past 18 years, most recently at $187.0 million for Q1 2026.

  • Quarterly Change in Taxes rose 246.3% to $187.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $129.0 million through Mar 2026, up 106.1% year-over-year, with the annual reading at -$4.0 million for FY2025, 99.68% up from the prior year.
  • Change in Taxes was $187.0 million for Q1 2026 at Bristol Myers Squibb, up from -$324.0 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $1.0 billion in Q4 2023 and troughed at -$2.1 billion in Q2 2023.
  • The 5-year median for Change in Taxes is $54.0 million (2025), against an average of -$182.5 million.
  • Year-over-year, Change in Taxes tumbled 786.67% in 2023 and then surged 354.89% in 2025.
  • A 5-year view of Change in Taxes shows it stood at -$1.1 billion in 2022, then soared by 193.8% to $1.0 billion in 2023, then tumbled by 88.41% to $121.0 million in 2024, then tumbled by 367.77% to -$324.0 million in 2025, then soared by 157.72% to $187.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Change in Taxes are $187.0 million (Q1 2026), -$324.0 million (Q4 2025), and $887.0 million (Q3 2025).